{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:15:42Z","timestamp":1772806542267,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>This report illustrates the importance of a detailed history and physical exam and careful analysis of hematologic parameters when diagnosing ITP. This case demonstrates that even with subtle deviations from typical ITP findings one must promptly reevaluate the diagnosis. This case also highlights the importance of peripheral smear review by an expert in pediatric hematopathology.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A previously healthy 10\u2009year-old Asian boy presented with 2 months of easy bruising. Review of systems was negative for any constitutional symptoms. On examination, he appeared well but had numerous large ecchymoses. He had no appreciable lymphadenopathy or splenomegaly. The liver was palpable 1.5\u2009cm below the costal margin. A complete blood count (CBC) showed: platelets\u2009=\u200917\u2009\u00d7\u2009109\/L, hemoglobin\u2009=\u2009128\u2009g\/L, white blood cell count\u2009=\u20095.43\u2009\u00d7\u2009109\/L, and neutrophils\u2009=\u20091.63\u2009\u00d7\u2009109\/L. A blood smear was reported as normal. Urate was 370 umol\/L and lactate dehydrogenase (LDH) was 803\u2009U\/L. The child was admitted with a presumptive diagnosis of immune thrombocytopenic purpura (ITP) and treated with intravenous immunoglobulin. The following day, the blood smear was reviewed by a hematopathologist who identified blasts. A bone marrow aspiration (BMA) confirmed the diagnosis of precursor B-cell acute lymphoblastic leukemia.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>In children presenting with suspected ITP, leukemia should always be considered. A BMA was historically performed on all patients with presumed ITP to rule out leukemia. In 2011, the American Society of Hematology (ASH) stopped recommending routine BMA in patients suspected of having ITP. ASH advises in cases with unusual findings on history, physical examination or CBC, it is reasonable to perform a BMA. Our patient had mild hepatomegaly, which may have qualified him for a BMA. He also had an elevated LDH and urate, which are not listed as criteria for BMA by ASH but were considered atypical for ITP by the clinical team. A literature search did not reveal any primary data assessing these markers.<\/jats:p>\n<jats:p>While corticosteroids are a first line treatment in ITP, they must be reserved for when clinicians are confident that the patient does not have leukemia. Steroid administration prior to diagnosing leukemia results in delayed diagnosis and may increase the risk of complications and decrease survival.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-019-6302-0","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T17:03:13Z","timestamp":1573059793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Teetering on a liver\u2019s edge: a case report highlighting clinical decision-making in thrombocytopenia"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8300-3095","authenticated-orcid":false,"given":"Adam","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Erdman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lillian","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,6]]},"reference":[{"issue":"11","key":"6302_CR1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1542\/pir.26-11-401","volume":"26","author":"G Buchanan","year":"2017","unstructured":"Buchanan G. Thrombocytopenia during childhood: what the pediatrician needs to know. Peds Rev. 2017;26(11):401\u20139.","journal-title":"Peds Rev"},{"issue":"16","key":"6302_CR2","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMp068169","volume":"355","author":"ME Bromberg","year":"2006","unstructured":"Bromberg ME. Immune thrombocytopenic purpura\u2013the changing therapeutic landscape. N Engl J Med. 2006;355(16):1643\u20135.","journal-title":"N Engl J Med"},{"key":"6302_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4274\/Tjh.2012.0049","volume":"31","author":"MS Evim","year":"2014","unstructured":"Evim MS, Baytan B, Gunes AM. Childhood immune thrombocytopenia: long term follow up data evaluated by the criteria of the international working group on immune thrombocytopenic purpura. Turk J Hematol. 2014;31:32\u20139.","journal-title":"Turk J Hematol"},{"issue":"2","key":"6302_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/08035250410025294","volume":"94","author":"B Zeller","year":"2005","unstructured":"Zeller B, Rajantie J, Hedlund-Treutiger I, et al. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr. 2005;94(2):178.","journal-title":"Acta Paediatr"},{"issue":"16","key":"6302_CR5","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","volume":"117","author":"C Neunert","year":"2011","unstructured":"Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guidelines for immune thrombocytopenia. Blood. 2011;117(16):4190\u2013207.","journal-title":"Blood"},{"key":"6302_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMra066469","volume":"357","author":"H Richard","year":"2007","unstructured":"Richard H, Aster MD, Bougie DW. Drug-induced immune thrombocytopenia. NEJM. 2007;357:580\u20137.","journal-title":"NEJM"},{"key":"6302_CR7","first-page":"1068","volume":"84","author":"SA Dubansky","year":"1989","unstructured":"Dubansky SA, Boyett JM, Falletta J, et al. Isolated thrombocytopenia in children with acute lymphoblastic leukemia: a rare event in a pediatric oncology group study. Pediatrics. 1989;84:1068\u201371.","journal-title":"Pediatrics"},{"key":"6302_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1001\/archpedi.152.4.345","volume":"152","author":"C Calpin","year":"1998","unstructured":"Calpin C, Dick P, Poon A, Feldman W. Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia? Arch Pediatr Adolesc Med. 1998;152:345\u20137.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"6302_CR9","first-page":"96","volume":"21","author":"YW Chu","year":"2000","unstructured":"Chu YW, Korb J, Sakamoto KM. Idiopathic thrombocytopenia Purpura. Peds Rev. 2000;21(3):96\u2013104.","journal-title":"Peds Rev"},{"key":"6302_CR10","first-page":"4385","volume":"19","author":"MS Dal","year":"2015","unstructured":"Dal MS, Karakus A, Aydin BB, Ekmen MO, Ulas T, Ayyildiz A. Serum uric acid and inflammation in patients with immune thrombocytopenic purpura: preliminary results. Eur Rev Med Pharmacol Sci. 2015;19:4385\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"6302_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.hoc.2009.11.004","volume":"24","author":"V Blanchette","year":"2010","unstructured":"Blanchette V, Bolton-Maggs P. Childhood immune thrombocytopenic purpura: diagnosis and management. Hematol Oncol Clin North Am. 2010;24(1):249\u201373.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"7","key":"6302_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/MPH.0000000000000120","volume":"36","author":"CE Beck","year":"2014","unstructured":"Beck CE, Boydell KM, Stasiulis E, et al. Shared decision making in management of children with newly diagnosed immune thrombocytopenia. J Pediatri Hematol Oncol. 2014;36(7):559\u201365.","journal-title":"J Pediatri Hematol Oncol"},{"issue":"4","key":"6302_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.arcped.2013.01.016","volume":"20","author":"S Gatineau-Saillant","year":"2013","unstructured":"Gatineau-Saillant S, Buchbinder N, Callat MP, et al. Steroid intake before leukemia diagnosis impairs outcomes in childhood acute lymphoblastic leukemia. Arch Peds. 2013;20(4):341\u20137.","journal-title":"Arch Peds"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6302-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6302-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6302-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:20:04Z","timestamp":1604535604000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6302-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,6]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6302"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6302-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,6]]},"assertion":[{"value":"20 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was not needed for this study. Consent to participate was obtained from the family of the patient described in the case.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to publish was obtained in writing from the father of the patient described in the case.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1058"}}